GGrantIndex
← Leaderboards

David A Hildeman

University Of Notre Dame

$13,398,639
Attributed
$23,030,598
Total exposure
16
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.7M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$23,030,598 · 16

By mechanism

R01$18,424,454 · 6
R21$2,578,246 · 6
R56$1,344,423 · 3
T32$683,475 · 1

Top collaborators

Others in their field

Top investigators on “Response

Research focus

ResponseCellsT-LymphocyteAntigensApoptoticMediatingPathway InteractionsApoptosisIn VivoPreventHomeostasisAffectAcuteT Cell ResponseMemoryPathogenPlayAutomobile DrivingInfectionCd8b1 GeneAutoimmunityCytokineCombatOrgan

Grant awards (56)

Proteasome Targeting for Alloreactive Plasma Cells$3,810,794
R01 · FY2025 · AI
Bringing alloreactivity into focus with the lens of TCR cross-reactivity$459,439
R21 · FY2025 · AI
Cell specific roles of CD153 and CD30 in regulation of immune responses$441,375
R21 · FY2025 · AI · contact PI
Proteasome targeting for alloreactive plasma cells$656,105
R01 · FY2024 · AI
Decoding human T-cell allospecificity$198,878
R21 · FY2024 · AI
Proteasome targeting for alloreactive plasma cells$656,561
R01 · FY2023 · AI
Decoding human T-cell allospecificity$264,776
R21 · FY2023 · AI
Proteasome targeting for alloreactive plasma cells$688,803
R01 · FY2022 · AI
Proteasome targeting for alloreactive plasma cells$691,721
R01 · FY2021 · AI
Metabolic alterations in age-associated dendritic cell dysfunction$494,954
R01 · FY2021 · AG
Regulation and function of immune suppressive T cells in aging$325,950
R56 · FY2021 · AG
Proteasome targeting for alloreactive plasma cells$701,208
R01 · FY2020 · AI
Metabolic alterations in age-associated dendritic cell dysfunction$494,954
R01 · FY2020 · AG
Single cell analysis of transplant rejection$199,026
R21 · FY2020 · AI · contact PI
Pathogenesis and therapeutic targeting of immune disorders$131,538
T32 · FY2020 · AI · contact PI
Homeostasis and function of regulatory T cells in aging$643,473
R56 · FY2019 · AG
Metabolic alterations in age-associated dendritic cell dysfunction$494,937
R01 · FY2019 · AG
Single cell analysis of transplant rejection$253,473
R21 · FY2019 · AI · contact PI
Pathogenesis and therapeutic targeting of immune disorders$141,626
T32 · FY2019 · AI · contact PI
Metabolic alterations in age-associated dendritic cell dysfunction$503,582
R01 · FY2018 · AG
Novel therapeutic target for intrauterine inflammation$195,000
R21 · FY2018 · HD · contact PI
Homeostasis and function of regulatory T cells in aging$159,000
R01 · FY2018 · AG
Pathogenesis and therapeutic targeting of immune disorders$127,622
T32 · FY2018 · AI · contact PI
Exploiting the DNA damage response to selectively sculpt the T cellrepertoire$390,000
R01 · FY2017 · AI
Novel therapeutic target for intrauterine inflammation$234,000
R21 · FY2017 · HD
Pathogenesis and therapeutic targeting of immune disorders$142,103
T32 · FY2017 · AI · contact PI
Homeostasis and function of regulatory T cells in aging$411,710
R01 · FY2016 · AG
Exploiting the DNA damage response to selectively sculpt the T cellrepertoire$390,000
R01 · FY2016 · AI
Pathogenesis and therapeutic targeting of immune disorders$140,586
T32 · FY2016 · AI · contact PI
Homeostasis and function of regulatory T cells in aging$445,262
R01 · FY2015 · AG
Exploiting the DNA damage response to selectively sculpt the T cellrepertoire$390,000
R01 · FY2015 · AI
Homeostasis and function of regulatory T cells in aging$167,250
R01 · FY2015 · AG
Homeostasis and function of regulatory T cells in aging$459,033
R01 · FY2014 · AG
Exploiting the DNA damage response to selectively sculpt the T cellrepertoire$390,000
R01 · FY2014 · AI
Control of Diabetes by Manipulation of Bc12 Family Members$332,775
R01 · FY2014 · DK
Homeostasis and function of regulatory T cells in aging$389,066
R01 · FY2013 · AG
Regulation of Apoptosis in Activated Primary T Cells$347,817
R01 · FY2013 · AI · contact PI
Control of Diabetes by Manipulation of Bc12 Family Members$321,129
R01 · FY2013 · DK
Homeostasis and function of regulatory T cells in aging$43,988
R01 · FY2013 · AG
Homeostasis and function of regulatory T cells in aging$424,960
R01 · FY2012 · AG
Regulation of Apoptosis in Activated Primary T Cells$369,946
R01 · FY2012 · AI · contact PI
Control of Diabetes by Manipulation of Bc12 Family Members$332,775
R01 · FY2012 · DK
Control of Diabetes by Manipulation of Bc12 Family Members$382,500
R01 · FY2011 · DK
Regulation of Apoptosis in Activated Primary T Cells$369,877
R01 · FY2011 · AI · contact PI
Homeostasis and function of regulatory T cells in aging$99,844
R01 · FY2011 · AG
Homeostasis and function of regulatory T cells in aging$472,528
R01 · FY2010 · AG
Regulation of Apoptosis in Activated Primary T Cells$375,527
R01 · FY2010 · AI · contact PI
Regulation of Apoptosis in Activated Primary T Cells$102,311
R01 · FY2010 · AI · contact PI
Homeostasis and function of regulatory T cells in aging$472,498
R01 · FY2009 · AG
Regulation of Apoptosis in Activated Primary T Cells$106,496
R01 · FY2009 · AI · contact PI
Regualtion of Apoptosis in Activated Primary T Cells$375,000
R56 · FY2008 · AI · contact PI
Regulation of Apoptosis in Activated Primary T cells$353,197
R01 · FY2007 · AI · contact PI
IL-1 dependent anorexia during CNS viral infection$163,857
R21 · FY2007 · NS · contact PI
Regulation of Apoptosis in Activated Primary T cells$363,746
R01 · FY2006 · AI · contact PI
IL-1 dependent anorexia during CNS viral infection$168,422
R21 · FY2006 · NS · contact PI
Regulation of Apoptosis in Activated Primary T cells$367,600
R01 · FY2005 · AI